a clinical-stage biopharmaceutical company developing tumour immunotherapy
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MDVNX | 10.77 | N/A | N/A |
MassMutual Diversified Value R3 | |||
FPPUX | 11.83 | -0.01 | -0.08% |
MFS Prudent Investor R4 | |||
SVACX | 6.24 | -0.02 | -0.32% |
Federated Hermes Strategic Value Div C | |||
RDWFX | 10.66 | -0.07 | -0.65% |
American Funds Dvlpg Wld Gr&Inc R5 | |||
BLYCX | 32.89 | -0.78 | -2.32% |
American Beacon Man Lg Cp Growth C |
A.I.dvisor indicates that over the last year, CVAC has been loosely correlated with MDGL. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CVAC jumps, then MDGL could also see price increases.
Ticker / NAME | Correlation To CVAC | 1D Price Change % | ||
---|---|---|---|---|
CVAC | 100% | -4.87% | ||
MDGL - CVAC | 42% Loosely correlated | -4.66% | ||
AXON - CVAC | 39% Loosely correlated | -0.86% | ||
VIR - CVAC | 35% Loosely correlated | -7.29% | ||
SPRB - CVAC | 34% Loosely correlated | -5.83% | ||
BNTX - CVAC | 33% Loosely correlated | -3.71% | ||
More |